1108746-98-0 Usage
Molecular Structure
Contains a chloro, indazolyl, pyridine, and tetrahydropyran group
Pharmaceutical Potential
Potential antineoplastic and antitumor agent
Moiety
Contains a pyridine-3-carboxamide moiety commonly found in anticancer drugs
Biological Effects
Difluorobenzyl group associated with inhibitory effects on certain enzymes and biological pathways
Unique Properties
Specific combination of chemical groups and substructures suggests potentially unique and beneficial pharmaceutical properties
Check Digit Verification of cas no
The CAS Registry Mumber 1108746-98-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,8,7,4 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1108746-98:
(9*1)+(8*1)+(7*0)+(6*8)+(5*7)+(4*4)+(3*6)+(2*9)+(1*8)=160
160 % 10 = 0
So 1108746-98-0 is a valid CAS Registry Number.
1108746-98-0Relevant academic research and scientific papers
SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
-
Page/Page column 140, (2009/03/07)
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.
